Professional Documents
Culture Documents
Dr Sarah Jackson
Principal Research Fellow
UCL Tobacco and Alcohol Research Group
s.e.jackson@ucl.ac.uk @DrSarahEJackson
Outline
2
Outline
3
Cigarette smoking in the UK
4
Cigarette smoking in the UK by age group
5
Cigarette smoking in the UK by occupational group
6
Outline
• Smoking trends
• Health effects of smoking and benefits of stopping
• Why people smoke and find it hard to stop
• Stopping smoking
7
Diseases at least partially caused by smoking
• Aortic aneurism (causing rupture of the main blood supply from the heart)
• Back pain
• Buerger’s disease (leading to amputations)
• Cancer of the bladder
• Cancer of the cervix
• Cancer of the lung, trachea and bronchus1
• Cancer of the mouth
• Cancer of the oesophagus
• Cancer of the pancreas
• Cancer of the stomach
8
1
Major cause of death
Diseases at least partially caused by smoking
9
Major cause of death
1
Diseases at least partially caused by smoking
10
Major cause of death
1
Diseases at least partially caused by smoking
11
Diseases made worse by smoking
• Asthma
• Crohn’s disease (inflamed bowel)
• Graves’ disease (overactive thyroid gland)
• Multiple Sclerosis
12
Effect on mortality
13
Effect on mortality
14
Effect on mortality
15
Benefits of cessation
16
Doll et al (2004) BMJ
Benefits of cessation
17
Doll et al (2004) BMJ
Outline
• Smoking trends
• Health effects of smoking and benefits of stopping
• Why people smoke and find it hard to stop
• Stopping smoking
18
Addiction to cigarettes
• Cigarettes deliver nicotine rapidly to the brain via the pulmonary circulation in
a form that is convenient and palatable
• Nicotine delivered in this way is highly addictive
• The primary mechanism is ‘operant learning’
– Smoking is rewarded (‘positive reinforcement’)
– Abstinence is punished (‘negative reinforcement’)
19
Addiction to cigarettes
• Cigarettes deliver nicotine rapidly to the brain via the pulmonary circulation in
a form that is convenient and palatable
• Nicotine delivered in this way is highly addictive
• The primary mechanism is ‘operant learning’
– Smoking is rewarded (‘positive reinforcement’)
– Abstinence is punished (‘negative reinforcement’)
20
Positive reinforcement
21
Positive reinforcement
22
Positive reinforcement
23
Positive reinforcement
• The dopamine release ‘teaches’ the smoker to repeat the action of puffing on
a cigarette just like feeding a dog teaches it to sit up and beg
24
Negative reinforcement
25
Negative reinforcement
26
Nicotine withdrawal symptoms
Symptom Duration
Irritability/aggression < 4 weeks
Depression < 4 weeks
Restlessness < 4 weeks
Poor concentration < 2 weeks
Increased appetite/weight gain >10 weeks
Light-headedness <48 hours
Night-time awakenings < 1 week
Constipation >2 weeks
Coughs/colds/mouth ulcers >2 weeks
Urges to smoke >2 weeks
27
The double ‘whammy’
28
Addiction to cigarettes
I really want to
stop smoking: it’s
costing me money
and it will probably
kill me
Just
smoke
29
Outline
• Smoking trends
• Health effects of smoking and benefits of stopping
• Why people smoke and find it hard to stop
• Stopping smoking
30
The secret to stopping smoking
31
Motivating quit attempts
• Increase cost
• Smokefree legislation
• Health practitioner advice on quitting
• Advertising bans
• Mass media campaigns
32
The secret to stopping smoking
33
When the urge is stronger than resolve and
cigarettes are available, a lapse will occur
Urge to smoke
Time
Urge to smoke
Time
20
↑ % abstinent >6m
15
10
0
Varenicline Single form Dual form NRT for Varenicline
NRT NRT* 'reduce to for 'reduce
quit' to quit'
Data from RCTs; Cochrane reviews (NRT 2013; Varenicline 2016); Wu 2015
doi:10.3390/ijerph120910235; *Estimated by combining effect sizes; All comparisons are
36
active medication versus placebo in context of behavioural support
Psychological support
16
14
↑ % abstinent >6m
12
10
8
6
4
2
0
Data from RCTs; Cochrane reviews (2008, 2009, 2013, 2016); Indirect estimates compared
with nothing; Insufficient data on smartphone apps; Mixed data on websites
37
E-cigarettes & cessation
1
Cochrane Database Syst Rev. 2020:CD010216; Hajek, P., et al. (2019). New England Journal of Medicine 380(7): 629-637.
2
Jackson, S., Kotz, D., West, R., and Brown, J. (2019) Addiction, doi: 10.1111/add.12623; McNeill, Brose et al, PHE, 2018
E-cigarettes & cessation
1
Kalkhoran & Glantz. 2016 Feb;4(2):116-28.
2
Abrams et al, Annu Rev Public Health, 2018.
E-cigarette use
60 Current use in past-year smokers 60 Use in a quit attempt
50 50
40 40
Percent
30 30
20 20
10 10
0 0
0 7 0 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 0 7 0 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7
20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20
N=51867 adults who smoke or who stopped in the past year N=18561 adults who smoked and tried to stop in the past year
40
Quit success and attempts
60
Success
60 Quit attempts
50 50
40 40
Percent
30 30
20 20
10 10
0 0
0 7 0 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 0 7 0 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7
20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20
N=18561 adults who smoked and tried to stop in the past year N=51867 adults who smoke or who stopped in the past year
41
Use of other support in a quit attempt
60
50
40 NRT OTC
Beh'l support
30
Zyban
Champix
20
NRT Rx
10 No support
0
0 07 008 009 010 011 012 013 014 015 016 017
2 2 2 2 2 2 2 2 2 2 2
N=18561 adults who smoked and tried to stop in the past year
42
• Success rate of quit attempts increased
0.058% (0.038 to 0.078; P<0.001) for every
1% increase in the prevalence of e-cigarette
use during a recent quit attempt
• No clear evidence for association between e-
cigarette use and:
– quit attempts (β 0.025; 95% confidence
interval −0.035 to 0.085; P=0.41)
– use of NRT bought over the counter (β
0.006; −0.088 to 0.077; P=0.89)
– overall use of prescription treatment (β
−0.070; −0.152 to 0.013; P=0.10)
– use of behavioural support (β −0.013;
−0.102 to 0.077; P=0.78)
Interpretation
46